Last reviewed · How we verify

NCT03835039

The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy

Terminated Last updated 15 March 2022
What this trial tests

trial testing NIRS in HIE - Perinatal Hypoxic - Ischemic Encephalopathy in 101 participants. Terminated before completion.

Timeline
3 January 2019
Primary endpoint
1 January 2022
1 January 2022

Quick facts

Lead sponsorAlbany Medical College
StatusTerminated
Study typeOBSERVATIONAL
Enrollment101
Start date3 January 2019
Primary completion1 January 2022
Estimated completion1 January 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Albany Medical College

Who can join

Adults 1 Minute to 2, any sex, with HIE - Perinatal Hypoxic - Ischemic Encephalopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A longitudinal study evaluating the predictive ability of near infrared spectroscopy to predict brain injury in infants with hypoxic ischemic encephalopathy. Data will be analyzed at two different time periods, at discharge and again at 2 years of age.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of NIRS

Trials testing the same drug.

Other Albany Medical College trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03835039.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing